SLNO icon

Soleno Therapeutics
SLNO

Overview Fund Activity

21 hedge funds and large institutions have $7.06M invested in Soleno Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 7 closing their positions.

Holders
21
Holders Change
-5
Holders Change %
-19.23%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
5
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CG
1
Carlyle Group
District of Columbia
$2.54M
2
JGC
2
J. Goldman & Co
New York
$577K
3
NCM
3
Nantahala Capital Management
Connecticut
$1.5M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$150K
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$64.5K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
TSS
2
Two Sigma Securities
New York
$0
3
E
3
Ergoteles
New York
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
TRCT
5
Tower Research Capital (TRC)
New York
$6K
Name Market Value Shares Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
– – -100 Closed
Morgan Stanley
27
Morgan Stanley
New York
– – -14 Closed
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
– – -6 Closed
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
1
2